Miho Aoshima

Title: Miho Aoshima: Innovator in Enzyme Development

Introduction

Miho Aoshima is a notable inventor based in Saitama, Japan. She has made significant contributions to the field of biochemistry, particularly in the development of novel enzymes with potential therapeutic applications. Her work focuses on the enzyme arginine deiminase, which has shown promise as an anti-cancer agent.

Latest Patents

Miho Aoshima holds a patent for "Arginine deiminase from a Mycoplasma arginini strain." This innovative enzyme, with a molecular weight of approximately 45,000, is derived from mycoplasma and possesses the ability to decompose arginine. The method of manufacturing this enzyme from mycoplasma is also detailed in her patent. The enzyme has demonstrated effective anti-cancer activities both in vitro and in vivo, highlighting its potential as a therapeutic agent.

Career Highlights

Miho Aoshima is currently employed at Nippon Mining Co., Ltd. Her work at the company has allowed her to explore the applications of her research in practical settings. Aoshima's dedication to her field is evident in her innovative approach to enzyme development.

Collaborations

Some of her notable coworkers include Karuo Takaku and Kaoru Miyazaki. Their collaboration has contributed to the advancement of research in enzyme technology and its applications in medicine.

Conclusion

Miho Aoshima's contributions to the field of biochemistry, particularly through her patent on arginine deiminase, showcase her innovative spirit and dedication to advancing medical science. Her work has the potential to impact cancer treatment significantly.